Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: The Chin-Shan Community Cardiovascular Cohort study

American Heart Journal

Volumn 156, Issue 5, 2008, Pages 996-1002

  Chien, Kuo Liong ^a,b,c   Hsu, Hsiu Ching ^b   Su, Ta Chen ^b   Chen, Ming Fong ^b   Lee, Yuan Teh ^b   Hu, Frank B ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; COHORT ANALYSIS; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STROKE; TAIWAN;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 54349109531     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.06.019     Document Type: Article

References (28)

1. DeFronzo R.A., Ferrannini E., and Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38 (1989) 387-395
2. Unwin N., Shaw J., Zimmet P., et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19 (2002) 708-723
3. Davies M.J., Raymond N.T., Day J.L., et al. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17 (2000) 433-440
4. Meyer C., Pimenta W., Woerle H.J., et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29 (2006) 1909-1914
5. Matthws D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and ?cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
6. Katz A., Nambi S.S., Mather K., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
7. Gutt M., Davis C.L., Spitzer S.B., et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47 (2000) 177-184
8. Yamagishi S., Nakamura K., and Takeuchi M. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. Med Hypotheses 65 (2005) 152-154
9. Chien K.L., Hsu H.C., Sung F.C., et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 183 (2005) 147-155
10. Lee Y.T., Lin R.S., Sung F.C., et al. Chin-Shan Community Cardiovascular Cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. Journal of Clinical Epidemiology 53 (2000) 836-846
11. Chien K.L., Lee Y.T., Sung F.C., et al. Hyperinsulinemia and related atherosclerotic risk factors in the population at cardiovascular risk: a community-based study. Clinical Chemistry 45 (1999) 838-846
12. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
13. Tan C.E., Ma S., Wai D., et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
14. Greiner M., Pfeiffer D., and Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45 (2000) 23-41
15. The DECODE study group, and European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354 (1999) 617-621
16. Decode Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
17. Cavalot F., Petrelli A., Traversa M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91 (2006) 813-819
18. Qiao Q., Pyorala K., Pyorala M., et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 23 (2002) 1267-1275
19. Tominaga M., Eguchi H., Manaka H., et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
20. Sorkin J.D., Muller D.C., Fleg J.L., et al. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28 (2005) 2626-2632
21. Coutinho M., Gerstein H.C., Wang Y., et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
22. Wei M., Gibbons L.W., Mitchell T.L., et al. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 101 (2000) 2047-2052
23. Svensson A.M., McGuire D.K., Abrahamsson P., et al. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26 (2005) 1255-1261
24. Blake D.R., Meigs J.B., Muller D.C., et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53 (2004) 2095-2100
25. Hanefeld M., Temelkova-Kurktschiev T., Schaper F., et al. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16 (1999) 212-218
26. Li C.L., Tsai S.T., and Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study. J Clin Epidemiol 55 (2002) 19-24
27. Wang J.J., Yuan S.Y., Zhu L.X., et al. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. Diabetes Res Clin Pract 66 (2004) 183-191
28. Lawes C.M., Parag V., Bennett D.A., et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27 (2004) 2836-2842